Top Markets
Coin of the day
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Rang in aandelen #41145
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Aandeelprijs
$0.04082105
Laatst gesynchroniseerd: 2024-08-12
Marktkapitalisatie
$39.09K
Verandering (1 dag)
-19.83%
Verandering (1 jaar)
0.00%
Land
GB
Handel Destiny Pharma plc (DEST)

Categorie

Winst voor Destiny Pharma plc (DEST)
Winst in Dec 2023 TTM: $-8.21M
Volgens de meest recente financiële verslagen van Destiny Pharma plc bedraagt de huidige winst van het bedrijf $-8.21M. In 2022 behaalde het bedrijf een winst van $-9.33M, een daling ten opzichte van de winst van 2021, die $-8.48M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Destiny Pharma plc van 2013 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-8.21M 0.00%
2023 $-8.21M -12.04%
2022 $-9.33M 10.03%
2021 $-8.48M -4.31%
2020 $-8.86M 21.02%
2019 $-7.32M -4.32%
2018 $-7.65M 76.32%
2017 $-4.34M 142.61%
2016 $-1.79M 1.42%
2015 $-1.76M -45.18%
2014 $-3.22M 174.64%
2013 $-1.17M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$5.27B -64,380.54%
US
$1.95B -23,870.85%
NL
- -
CH
- -
KR
$3.01B -36,728.02%
BE